Document Type
Article
Publication Date
Spring 11-2-2026
Abstract
Hepatocellular carcinoma (HCC) is one of the most common malignancies and among the leading causes of cancer-related mortality worldwide. Egypt has one of the highest HCC incidence rates, with distinct genetic and non-genetic risk factors. We performed whole exome sequencing to identify cancer-related germline pathogenic/likely pathogenic (P/LP) variants in 224 HCC adult patients, 117 with cirrhosis, and no evidence of HCC. Genomic data of 503 apparently healthy Egyptians were used as a comparator. Moreover, we evaluated the liver-related pharmacogenomic variants and conducted a Genome-Wide Association Study (GWAS) to detect germline common variants associated with HCC and liver cirrhosis in Egyptian patients. In the HCC group, 34/224 (15.2%) reported a family history of HCC and 14/224 (6.3%) reported other cancers, whereas in the cirrhosis group, 32/117 (27.4%) had a family history of HCC and 6/117 (5.1%) reported other cancers. We detected 95/224 HCC patients with P/LP cancer-related germline variants, including 41/224 (18.3%) having variants in cancer predisposition genes (CPG), compared to 54/117 in the non-HCC cirrhosis patients with 20/117 (17.1%) in CPG. MUTYH, APC, FH, PDE11A, BRCA1, BRCA2, EXT2, FANCA, and MCPH1 were the most commonly encountered genes. Variants in IFNL3 and IFNL4 associated with improved response to HCV antiviral therapy were more frequent in cirrhosis, while TNF and UGT1A9 variants associated with sorafenib toxicity were more common in HCC. In GWAS, common variants in 20 genes, including ADGRE5, BAGE2, MUC6, SLC35E2B, NBPF1, ZNF595, and NANOGP1, were significantly higher in both HCC and cirrhosis patients compared to the healthy population. To our knowledge, this study is the first to evaluate germline genetic variants and its clinical implications in Egyptian HCC and cirrhotic patients. Our findings would significantly impact Egyptian HCC and cirrhosis patient management protocols and help establish a foothold for HCC precision medicine in Egypt.
Recommended Citation
Ramadan, Eman, "Germline cancer predisposition variants and pharmacogenomic landscape of hepatocellular carcinoma in Egyptian patients" (2026). Pharmacy. 970.
https://buescholar.bue.edu.eg/pharmacy/970
Included in
Digestive System Diseases Commons, Genetic Processes Commons, Hepatology Commons, Medical Biotechnology Commons, Medical Genetics Commons, Medical Molecular Biology Commons, Neoplasms Commons